Safety and effectiveness of dupilumab in the real‐world treatment of atopic dermatitis in Japan: 1‐year interim analysis from a post‐marketing surveillance

• Main Authors: Hidehisa Saeki (Author), Hiroyuki Fujita (Author), Katsuhisa Suzuki (Author), Kazuhiko Arima (Author)
• Format: Knjiga
• Izdano: Frontiers Media S.A., 2023-06-01T00:00:00Z.
• Teme: article
• Online dostop: Connect to this object online.

Abstract Objectives Atopic dermatitis (AD) is a common chronic inflammatory skin disorder in Japan. Dupilumab, a fully human monoclonal antibody, targets a shared subunit of the interleukin (IL)‐4 and IL‐13 receptors. Post‐marketing surveillance of the safety and effectiveness of dupilumab in adult...